Skip to main content
Log in

Intestinal-type gastric dysplasia in Helicobacter pylori-naïve patients

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Gastric dysplasia and gastric cancer in Helicobacter pylori (Hp)-naïve patients usually exhibit a gastric phenotype, reflecting gastric mucosa without intestinal metaplasia (IM). We showed that intestinal-type gastric dysplasia (IGD) rarely occurs in the Hp-naïve stomach. In the last 10 years, we treated 1760 gastric dysplasia and gastric cancer patients, with 3.6% (63/1760) being Hp-naïve. Among these, ten were diagnosed with 14 IGDs and enrolled in this retrospective analysis. All lesions were observed by white-light endoscopy (WLE) and narrow-band imaging with magnification endoscopy (NBIME). We analyzed their endoscopic and microscopic features and patient demographics. Five men and five women aged 64 ± 21 years were included. WLE showed the depressed lesions mimicking a benign raised erosion in the prepyloric compartment. Multiple growths were confirmed in 30% (3/10) of patients. NBIME showed a near-regular microstructure and capillaries in 50% (7/14) of lesions with a gastritis-like appearance. Histologically, background mucosa was non-atrophic pyloric gland tissue, but 40.0% of samples (4/10) contained sporadic IM. Most of the lesions (8/14) were low-grade dysplasia, and others had a high-grade component, with one progressing to intramucosal carcinoma. The neoplastic surface was widely covered with foveolar epithelium in 57.1% (8/14). Immunohistochemically, neoplastic cells expressed CDX2 in all patients (14/14), MUC2 and CD10 in 92.9% (13/14), MUC5AC in 14% (2/14), and no expression of MUC6, showing an intestinal phenotype. Ki-67 was overexpressed with a mean labeling index of 58.3 ± 38.5%, and p-53 was overexpressed in 92.9% (13/14), regardless of the dysplastic grade. The IGD rarely occurs in Hp-naïve patients with distinctive clinicopathologic characteristics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kushima R, Lauwers GY, Rugge M. (2019) Gastric dysplasia. In: Digestive system tumors WHO Classification of Tumors Editorial Board (ed) Digestive System Tumors, 5th edn., WHO Press, Geneva pp 71–75

  2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:829–832

    Article  Google Scholar 

  3. Inoue M (2017) Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer 20:3–7

    Article  CAS  PubMed  Google Scholar 

  4. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K (2011) Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 16:415–419

    Article  PubMed  Google Scholar 

  5. Kiso M, Yoshihara M, Ito M, Inoue K, Kato K, Nakajima S, Mabe K, Kobayashi M, Uemura N, Yada T, Oka M, Kawai T, Boda T, Kotachi T, Masuda K, Tanaka S, Chayama K (2017) Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer 20:764–771

    Article  CAS  PubMed  Google Scholar 

  6. Ono S, Kato M, Suzuki M, Ishigaki S, Takahashi M, Haneda M, Mabe K, Shimizu Y (2012) Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion 86:59–65

    Article  PubMed  Google Scholar 

  7. Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, Iwashita A, Watanabe S (2010) Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 34:609–619

    Article  PubMed  Google Scholar 

  8. Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S (2014) Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 46:153–157

    Article  PubMed  Google Scholar 

  9. Shibagaki K, Mishiro T, Fukuyama C, Takahashi Y, Itawaki A, Nonomura S, Yamashita N, Kotani S, Mikami H, Izumi D, Kawashima K, Ishimura N, Nagase M, Araki A, Ishikawa N, Maruyama R, Kushima R, Ishihara S (2021) Sporadic foveolar-type gastric adenoma with a raspberry-like appearance in Helicobacter pylori-naïve patients. Virchows Arch. https://doi.org/10.1007/s00428-021-03124-3

    Article  PubMed  Google Scholar 

  10. Yamada A, Kaise M, Inoshita N, Toba T, Nomura K, Kuribayashi Y, Yamashita S, Furuhata T, Kikuchi D, Matsui A, Mitani T, Ogawa O, Iizuka T, Hoteya S (2018) Characterization of Helicobacter pylori-naïve early gastric cancers. Digestion 98:127–134

    Article  CAS  PubMed  Google Scholar 

  11. Kotani S, Miyaoka Y, Fujiwara A, Tsukano K, Ogawa S, Yamanouchi S, Kusunoki R, Fujishiro H, Kohge N, Ohnuma H, Kinoshita Y (2016) Intestinal-type gastric adenocarcinoma without Helicobacter pylori infection successfully treated with endoscopic submucosal dissection. Clin J Gastroenterol 9:228–232

    Article  PubMed  Google Scholar 

  12. Ozaki Y, Suto H, Nosaka T, Saito Y, Naito T, Takahashi K, Ofuji K, Matsuda H, Ohtani M, Hiramatsu K, Nemoto T, Imamura Y, Nakamoto Y (2015) A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J Gastroenterol 8:18–21

    Article  PubMed  Google Scholar 

  13. Yoshii S, Hayashi Y, Takehara T (2017) Helicobacter pylori-negative early gastric adenocarcinoma with complete intestinal mucus phenotype mimicking verrucous gastritis. Dig Endosc 29:235–236

    Article  PubMed  Google Scholar 

  14. Kishimoto K, Shibagaki K, Itawaki A, Tanaka S, Takahashi Y, Cho Y, Ikuta Y, Oshima N, Nagasaki M, Ishihara S (2020) Synchronously multiple gastric adenocarcinomas with intestinal mucin phenotype in patient not infected with Helicobacter pylori, showing gastritis-like appearance. Intern Med 59:3155–3159

    Article  PubMed  PubMed Central  Google Scholar 

  15. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161–1181

    Article  CAS  PubMed  Google Scholar 

  16. Kishikawa H, Kimura K, Takarabe S, Kaida S, Nishida J (2015) Helicobacter pylori antibody titer and gastric cancer screening. Dis Markers. https://doi.org/10.1155/2015/156719

    Article  PubMed  PubMed Central  Google Scholar 

  17. Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H (2016) Gastric cancer. The Lancet 388:2654–2664

    Article  Google Scholar 

  18. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 23:700–713

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sjödahl K, Lu Y, Nilsen TI, Ye W, Hveem K, Vatten L, Lagergren J (2007) Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer 120:128–132

    Article  PubMed  Google Scholar 

  20. Lott PC, Carvajal-Carmona LG (2018) Resolving gastric cancer etiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol 3:874–883

    Article  PubMed  PubMed Central  Google Scholar 

  21. Shibagaki K, Amano Y, Ishimura N, Taniguchi H, Fujita H, Adachi S, Kakehi E, Fujita R, Kobayashi K, Kinoshita Y (2016) Diagnostic accuracy of magnification endoscopy with acetic acid enhancement and narrow-band imaging in gastric mucosal neoplasms. Endoscopy 48:16–25

    PubMed  Google Scholar 

  22. Muto M, Yao K, Kaise M, Kato M, Uedo N, Yagi K, Tajiri H (2016) Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc 28:379–393

    Article  PubMed  Google Scholar 

  23. Yagi K, Nakamura A, Sekine A (2002) Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylori infection. J Gastroenterol Hepatol 17:39–45

    Article  PubMed  Google Scholar 

  24. Montgomery EA, Sekine S, Singhi AD (2019) Intestinal-type gastric adenoma. In: Digestive system tumors WHO Classification of Tumors Editorial Board (ed), 5th edn, WHO Press, Geneva, pp71–75

  25. Tamai N, Kaise M, Nakayoshi T, Katoh M, Sumiyama K, Gohda K, Yamasaki T, Arakawa H, Tajiri H (2006) Clinical and endoscopic characterization of depressed gastric adenoma. Endoscopy 38:391–394

    Article  CAS  PubMed  Google Scholar 

  26. Jung MK, Jeon SW, Park SY, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Bae HI (2008) Endoscopic characteristics of gastric adenomas suggesting carcinomatous transformation. Surg Endosc 22:2705–2711

    Article  PubMed  Google Scholar 

  27. Yoshii S, Mabe K, Watano K, Ohno M, Matsumoto M, Ono S, Kudo T, Nojima M, Kato M, Sakamoto N (2020) Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis. Dig Endosc 32:74–83

    Article  PubMed  Google Scholar 

  28. Kobayashi M, Hashimoto S, Nishikura K, Mizuno K, Takeuchi M, Sato Y, Ajioka Y, Aoyagi Y (2013) Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol 48:1332–1342

    Article  CAS  PubMed  Google Scholar 

  29. Saka A, Yagi K, Nimura S (2016) Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer 19:524–530

    Article  CAS  PubMed  Google Scholar 

  30. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K (1993) Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 67:589–593

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Maehara Y, Tomoda M, Hasuda S, Kabashima A, Tokunaga E, Kakeji Y, Sugimachi K (1999) Prognostic value of p53 protein expression for patients with gastric cancer: a multivariate analysis. Br J Cancer 79:1255–1261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kushima R, Müller W, Stolte M, Borchard F (1996) Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis. Virchows Arch 428(4–5):223–227

    CAS  PubMed  Google Scholar 

  33. Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, Mustafa RA (2020) AGA technical review on gastric intestinal metaplasia-natural history and clinical outcomes. Gastroenterology 158(3):705–731

    Article  PubMed  Google Scholar 

  34. Liu T, Song X, Khan S, Li Y, Guo Z, Li C, Wang S, Dong W, Liu W, Wang B, Cao H (2020) The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: an old story, yet mesmerizing. Int J Cancer 146:1780–1790

    Article  CAS  PubMed  Google Scholar 

  35. Matsuhisa T, Arakawa T, Watanabe T, Tokutomi T, Sakurai K, Okamura S, Chono S, Kamada T, Sugiyama A, Fujimura Y, Matsuzawa K, Ito M, Yasuda M, Ota H, Haruma K (2013) Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. Dig Endosc 25:519–525

    Article  PubMed  Google Scholar 

  36. Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, Farthing MJ (2002) Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut 51(3):316–322

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Lenti MV, Rugge M, Lahner E, Miceli E, Toh BH, Genta RM, De Block C, Hershko C, Di Sabatino A (2020) Autoimmune gastritis. Nat Rev Dis Primers. 6(1):56. https://doi.org/10.1038/s41572-020-0187-8

    Article  PubMed  Google Scholar 

  38. Anagnostopoulos GK, Yao K, Kaye P, Fogden E, Fortun P, Shonde A, Foley S, Sunil S, Atherton JJ, Hawkey C, Ragunath K (2007) High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy 39:202–207

    Article  CAS  PubMed  Google Scholar 

  39. Mannath J, Ragunath K (2010) Narrow band imaging and high-resolution endoscopy with magnification could be useful in identifying gastric atrophy. Dig Dis Sci 55:1799–1800

    Article  PubMed  Google Scholar 

  40. Hwang HJ, Nam SK, Park H, Park Y, Koh J, Na HY, Kwak Y, Kim WH, Lee HS (2020) Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer. J Pathol Transl Med 54(5):378–386

    Article  PubMed  PubMed Central  Google Scholar 

  41. Uedo N, Ishihara R, Iishi H, Yamamoto S, Yamamoto S, Yamada T, Imanaka K, Takeuchi Y, Higashino K, Ishiguro S, Tatsuta M (2006) A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy. 38(8):819–24

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conception and design: Kotaro Shibagaki.

Analysis and interpretation of the data: Kotaro Shibagaki, Ayako Itawaki, Yoichi Miyaoka, Kenichi Kishimoto, Hideyuki Onuma, Makoto Nagasaki, Mamiko Nagase, Asuka Araki, Kuichi Kadota, and Ryoji Kushima.

Enrollment of patients: Yusuke Takahashi, Ayako Itawaki, Satoshi Kotani, Kenichi Kishimoto, Naoki Oshima, and Kousaku Kawashima.

Critical revision of the article for important intellectual content: Tsuyoshi Mishiro, Norihisa Ishimura, Kuichi Kadota, Ryoji Kushima, and Shunji Ishihara.

Final approval of the article: Shunji Ishihara.

Corresponding author

Correspondence to Kotaro Shibagaki.

Ethics declarations

Ethics approval

The study protocol was approved by the medical ethics committee of Shimane University Hospital (study number: 4905, Date: September 18, 2020). Informed consent was obtained in the form of opt-out on the website from all participants.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Fig. S1

Typical gastritis-like appearance. Case 4: The depressed lesion with raised surrounding mucosa is seen in non-atrophic antral area (indicated with yellow arrow), which resembles a benign raised erosion (A). However, NBIME shows irregular microstructure and capillaries, suggesting neoplastic characteristics (B). Histologic examination shows the high-grade dysplasia with irregular architecture (C) and polygonal nuclei with loss of polarity (D). Case 6: Similar depressed lesion is seen in non-atrophic antral compartment (indicated with blue arrow) (E). NBIME shows almost regular microstructure, suggesting non-neoplastic characteristics (F). Histologic examination reveals a low-grade dysplasia (G) superficially covered with foveolar epithelium (H). (PNG 37827 kb)

High Resolution (TIF 8630 kb)

Fig. S2

Multiple IGD case (Case 10); modified from reference [14]. Three depressed lesions are seen in the non-atrophic prepyloric area (indicated with colored arrows) (A). Two lesions show an irregular microstructure that is partially regular at the center part of the lesions (indicated with black arrow) (B and C). The other one shows an irregular papillary microstructure (D). Neoplastic mapping on the resected specimen (E). The yellow-arrowed lesion is histologically low-grade dysplasia that is superficially covered with foveolar epithelium (F). Solitary erosion is seen at another prepyloric site (G). Histologic examination by biopsy shows intestinal metaplasia (H). (PNG 40602 kb)

High Resolution (TIF 9141 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shibagaki, K., Itawaki, A., Miyaoka, Y. et al. Intestinal-type gastric dysplasia in Helicobacter pylori-naïve patients. Virchows Arch 480, 783–792 (2022). https://doi.org/10.1007/s00428-021-03237-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-021-03237-9

Keywords

Navigation